Anavex Life Sciences Corp (AVXL)

[Amatuer17]

Just to remind the timeline of Rett announcements - see the date of PR 19th Jan 2017 - after 19 months, we are still in dark and speculating and no one knows when the trial will start.
The wording in last 10-q makes me suspect that M has faced some serious hurdle so he is not sure if it will start in 2018 as well.

So keep your glass half full - does not matter in terms of trial start or progress.

“ANAVEX 2-73 has U.S. FDA Orphan Drug Designation for Rett Syndrome

NEW YORK and Cincinnati, Ohio – January 19, 2017 – Anavex Life Sciences Corp. (Nasdaq: AVXL) and the International Rett Syndrome Foundation, doing business as Rettsyndrome.org today announced that Rettsyndrome.org has committed a financial grant of a minimum of $0.6 million to cover the majority of a planned U.S. multicenter Phase 2 clinical trial of ANAVEX 2-73 for the treatment of Rett syndrome.

Scheduled to begin in 2017, the trial will be a randomized, double blind, placebo-controlled study of ANAVEX 2-73 in patients with Rett syndrome lasting up to 12 weeks.”